Clinical trial

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

NCT02210806

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE2

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2017-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

A006 DPIDRUG

Placebo DPIOTHER

Proventil® MDIDRUG

Sponsors & collaborators

Amphastar Pharmaceuticals, Inc.lead sponsor

Mapped research locations

San AntonioTexas, United States1 MedfordOregon, United States1 San JoseCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02210806 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.